Literature DB >> 26555020

A2 /A2 B to B Renal Transplantation: Past, Present, and Future Directions.

C F Bryan1, W S Cherikh2, D A Sesok-Pizzini3.   

Abstract

One component of the new national kidney allocation system (KAS) in the United States that was implemented on December 4, 2014, was the allocation of kidneys from A2 and A2 B (A, non-A1 and AB, non-A1 B) deceased donors into blood group B candidates (A2 /A2 B → B). In so far as this is an important component of the new KAS that has the potential to further increase the access to transplantation for blood group B candidates on the waiting list, most of whom are minority candidates, we will review the body of evidence and historical perspectives that led to its inclusion in the new KAS. This review will also describe prospects for more widespread use of A2 /A2 B → B transplantation and a novel mechanism of humoral immunosuppression in B patients before and after transplantation with an A2 or A2 B kidney. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  ABO incompatibility; Organ Procurement and Transplantation Network (OPTN); clinical research/practice; donors and donation: deceased; kidney (allograft) function/dysfunction; kidney transplantation/nephrology; organ allocation

Mesh:

Substances:

Year:  2015        PMID: 26555020     DOI: 10.1111/ajt.13499

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  5 in total

1.  Impact of the new kidney allocation system A2/A2B → B policy on access to transplantation among minority candidates.

Authors:  Paulo N Martins; Margaux N Mustian; Paul A MacLennan; Jorge A Ortiz; Mohamed Akoad; Juan Carlos Caicedo; Gabriel J Echeverri; Stephen H Gray; Reynold I Lopez-Soler; Ganesh Gunasekaran; Beau Kelly; Constance M Mobley; Sylvester M Black; Carlos Esquivel; Jayme E Locke
Journal:  Am J Transplant       Date:  2018-03-31       Impact factor: 8.086

Review 2.  Accommodation in ABO-incompatible organ transplants.

Authors:  Mayara Garcia de Mattos Barbosa; Marilia Cascalho; Jeffrey L Platt
Journal:  Xenotransplantation       Date:  2018-05       Impact factor: 3.907

Review 3.  Past and Present Policy Efforts in Achieving Racial Equity in Kidney Transplantation.

Authors:  Irene K Kim; Paulo N Martins; Martha Pavlakis; Nwamaka D Eneanya; Rachel E Patzer
Journal:  Curr Transplant Rep       Date:  2022-05-24

4.  A Safe Anti-A2 Titer for a Successful A2 Incompatible Kidney Transplantation: A Single-center Experience and Review of the Literature.

Authors:  Yorg Azzi; Gayatri Nair; Pablo Loarte-Campos; Maria Ajaimy; Jay Graham; Luz Liriano-Ward; Cindy Pynadath; Joan Uehlinger; Michael Parides; Alesa Campbell; Adriana Colovai; Omar Alani; Marie Le; Stuart Greenstein; Milan Kinkhabwala; Juan Rocca; Enver Akalin
Journal:  Transplant Direct       Date:  2021-01-26

5.  Challenging the Role of Diet-Induced Anti-Neu5Gc Antibodies in Human Pathologies.

Authors:  Jean-Paul Soulillou; Emanuele Cozzi; Jean-Marie Bach
Journal:  Front Immunol       Date:  2020-06-09       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.